Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 5
1961 8
1962 10
1963 8
1964 17
1965 18
1966 21
1967 29
1968 32
1969 36
1970 33
1971 29
1972 18
1973 11
1974 26
1975 15
1976 12
1977 11
1978 8
1979 10
1980 11
1981 7
1982 18
1983 17
1984 15
1985 8
1986 15
1987 16
1988 19
1989 12
1990 17
1991 10
1992 13
1993 7
1994 11
1995 5
1996 4
1997 5
1998 2
1999 2
2000 7
2001 4
2002 3
2003 1
2005 3
2006 4
2007 7
2008 5
2009 2
2010 3
2011 3
2012 1
2013 2
2014 2
2016 1
2018 2
2019 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

624 results

Results by year

Filters applied: . Clear all
Page 1
Erythromycin ethylsuccinate-induced cholestasis.
Viteri AL, Greene JF Jr, Dyck WP. Viteri AL, et al. Gastroenterology. 1979 May;76(5 Pt 1):1007-8. Gastroenterology. 1979. PMID: 437404
A 52-year-old Caucasian female developed abdominal pain, fever, and jaundice after erythromycin ethylsuccinate administration. Similar symptoms followed the administration of the same drug 5 mo earlier. It is believed that this is the first published case of eryt …
A 52-year-old Caucasian female developed abdominal pain, fever, and jaundice after erythromycin ethylsuccinate administration. …
Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
Yakatan GJ, Rasmussen CE, Feis PJ, Wallen S. Yakatan GJ, et al. J Clin Pharmacol. 1985 Jan-Feb;25(1):36-42. doi: 10.1002/j.1552-4604.1985.tb02798.x. J Clin Pharmacol. 1985. PMID: 3871797 Clinical Trial.
Bioequivalence comparisons between erythromycin ethylsuccinate and an enteric-coated erythromycin base pellet product were made following multiple-dose, oral administration. ...Erythromycin ethylsuccinate is not bioequivalent to an enteric-coate …
Bioequivalence comparisons between erythromycin ethylsuccinate and an enteric-coated erythromycin base pellet product w …
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
Croteau D, Bergeron MG, LeBel M. Croteau D, et al. Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561. Antimicrob Agents Chemother. 1988. PMID: 3259856 Free PMC article. Clinical Trial.
The pharmacokinetics of erythromycin estolate (500 mg) and erythromycin ethylsuccinate (600 mg) were compared in 12 healthy volunteers after single doses and after repeated oral doses (every 8 h). High-pressure liquid chromatography with electrochemical detec …
The pharmacokinetics of erythromycin estolate (500 mg) and erythromycin ethylsuccinate (600 mg) were compared in 12 hea …
Erythromycin ethylsuccinate-induced cholestasis.
Bachman BA, Boyd WP Jr, Brady PG. Bachman BA, et al. Am J Gastroenterol. 1982 Jun;77(6):397-400. Am J Gastroenterol. 1982. PMID: 6979924 No abstract available.
Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
Bérubé D, Kirouac D, Croteau D, Bergeron MG, Lebel M. Bérubé D, et al. Antimicrob Agents Chemother. 1988 Aug;32(8):1227-30. doi: 10.1128/AAC.32.8.1227. Antimicrob Agents Chemother. 1988. PMID: 3142349 Free PMC article. Clinical Trial.
In a crossover design study, we compared the plasma bactericidal activities of erythromycin estolate (500 mg) and erythromycin ethylsuccinate (600 mg) after administration of a single oral dose to 12 healthy volunteers. ...Of the 60 plasma bactericidal activi …
In a crossover design study, we compared the plasma bactericidal activities of erythromycin estolate (500 mg) and erythromycin …
The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
Shanson DC, Tidbury P, McNabb WR, Tadayon M. Shanson DC, et al. J Antimicrob Chemother. 1984 Aug;14(2):157-63. doi: 10.1093/jac/14.2.157. J Antimicrob Chemother. 1984. PMID: 6334070
Serum concentrations of erythromycin were monitored in 11 healthy adult volunteers following single dose oral administration of erythromycin stearate, 1.5 g, and erythromycin ethylsuccinate 3.0 g. ...Both types of erythromycin frequently caused …
Serum concentrations of erythromycin were monitored in 11 healthy adult volunteers following single dose oral administration of er …
Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability.
Saloranta P, Roos L, Elonen E, Allonen H. Saloranta P, et al. J Antimicrob Chemother. 1989 Sep;24(3):455-62. doi: 10.1093/jac/24.3.455. J Antimicrob Chemother. 1989. PMID: 2808197 Clinical Trial.
The efficacy and tolerability of erythromycin ethylsuccinate, erythromycin base and erythromycin acistrate were studied in two separate randomized studies in 80 and 82 primary health care patients with upper respiratory tract infections. ...These studi …
The efficacy and tolerability of erythromycin ethylsuccinate, erythromycin base and erythromycin acistrate were …
Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
Lakritz J, Wilson WD, Marsh AE, Mihalyi JE. Lakritz J, et al. Vet Ther. 2002 Summer;3(2):189-95. Vet Ther. 2002. PMID: 19750750
Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin …
Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromy …
[Erythromycin ethylsuccinate obtaining possibilities].
Stan CD, Stefanache A, Tântaru G, Poiată A, Dumitrache M, Diaconu DE, Profire L. Stan CD, et al. Rev Med Chir Soc Med Nat Iasi. 2008 Oct-Dec;112(4):1104-9. Rev Med Chir Soc Med Nat Iasi. 2008. PMID: 20209795 Romanian.
In this study we tried to improve the erythromycin ethylsuccinate obtaining, having in view to separate the erythromycin ester by crystallization in water. ...The obtained erythromycin ethylsuccinate corresponds to the Xth edition of Romanian Ph …
In this study we tried to improve the erythromycin ethylsuccinate obtaining, having in view to separate the erythromycin …
624 results